English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Antimalarial drug resistance is one of the major challenges in global efforts to control and eliminate malaria. In 2006, sulfadoxine-pyrimethamine (SP) replaced with artemisinin-based combination therapy (ACT) on Bioko Island, Equatorial Guinea, in response to increasing SP resistance, which is associated with mutations in the dihydrofolate reductase ( Pfdhfr ) and dihydropteroate synthase ( Pfdhps ) genes.

infection and drug resistance

&lt;p&gt;Trends in Molecular Markers Associated with Resistance to Sulfadoxine-Pyrimethamine (SP) Among &lt;em&gt;Plasmodium falciparum&lt;/em&gt; Isolates on Bioko Island, Equatorial Guinea: 2011–2017&lt;/p&gt;